Risk factors
Syra Health (SYRA) risk factors
Item 1A of every Syra Health Corp. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors46 risks4 new1 dropped4 reworded
The company shifted from Nasdaq to the OTC QB market, introducing penny stock and broker suitability risks. Revenue concentration shifted between FSSA and Humana. Insiders retain heavy voting power.
Filed Mar 12, 2026 - FY2024 10-K risk factors43 risks
Syra Health faces heavy customer concentration with FSSA providing 61 percent of 2024 revenue. The auditor issued a going concern warning with cash at $2.39 million. Insiders control 30.9 percent of voting securities through dual-class shares.
Filed Mar 11, 2025